Skip to content

Clinical trials

Diabetes Mellitus, Type 1 trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Country / region: Japan Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20024
20033
20042
20072
20091
20104
20113
20126
20132
20141
20154
20165
20171
20182
20191
20201
20211
20221
20241
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Recruiting5
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S24
Eli Lilly and Company10
Sanofi9
AstraZeneca3
Astellas Pharma Inc2
Boehringer Ingelheim1
Pfizer1
Regeneron Pharmaceuticals1
Sanwa Kagaku Kenkyusho Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 152
Diabetes Mellitus23
Diabetes Mellitus, Type 210
Insulin Resistance1
Obesity1
Overweight1

Trials

Showing 26 to 50 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.